HUMAN SUBMUCOSAL GLAND AND BRONCHIOLAR SECRETIONS

描述（直接取自应用程序） 囊性纤维化（CF）支气管上皮细胞Cl 渗透性和增加的Na+吸收，这可能有助于 呼吸道分泌物异常和继发性感染是CF的典型特征。 粘膜下腺体表达高水平的CFTR mRNA和蛋白， 细支气管是CF最早的气道阻塞部位，但 这些结构对气道分泌物和液体平衡的贡献， 正常和CF肺是未知的。 该研究项目将评估 支气管粘膜下腺体和细支气管上皮对 正常和囊性纤维化人类气道中的液体和粘液平衡。 人类 从肺中取出支气管粘膜下腺体和细支气管上皮 在临床指征肺切除术期间，来自非CF和CF患者， 将评估移植手术。 粘膜下腺体的结构 细支气管的细胞分布将通过形态测定法评估。 粘膜下腺浆液细胞、粘液 细胞和纤毛细胞，以及收集管和 纤毛导管 细支气管上皮细胞将被鉴定为 纤毛，杯状，或克拉拉的特异性抗体识别的基础上。 离子转运蛋白CFTR和 人上皮Na+通道的α、β和γ亚基将被 通过原位杂交和免疫组织化学确定。 粘膜下 将测量腺体分泌量、离子组成和调节 使用容量移液管、离子选择性微电极和人 粘蛋白特异性ELISA。 支气管上皮电位差，气道 表面液体离子含量和离子传输调节将进行评估 用体内电位差静电计，离子选择性 微电极和转运激动剂和抑制剂。 这些形态测量， 基因定位和生理方法将使我们能够测试 假设粘膜下腺体分泌物的数量减少， 囊性纤维化和局部细支气管区，其中主要盐 并且发生吸水。 这提高了对人类的认识。 粘膜下腺体和细支气管生理学可以阐明 在囊性纤维化中是异常的， 接近。

DESCRIPTION (Taken directly from the application) Cystic fibrosis (CF) bronchial epithelial cells have decreased Cl permeability and increased Na+ absorption, which may contribute to the abnormal airway secretions and secondary infection that typifies CF. Submucosal glands express high levels of CFTR mRNA and protein, and bronchioles are the site of earliest airway obstruction in CF, but the contributions of these structures to airway secretions and fluid balance in normal and CF lungs are not known. This research project will assess the contributions of bronchial submucosal glands and bronchiolar epithelium to fluid and mucus balance in normal and cystic fibrosis human airways. Human bronchial submucosal glands and bronchiolar epithelium from lungs removed from non-CF and CF patients during clinically indicated lung resection and transplant operations will be evaluated. The structure of submucosal glands and cellular distribution of bronchioles will be assessed by morphometric techniques and markers specific for submucosal gland serous cells, mucous cells, and ciliated cells, and morphologic criteria for collecting ducts and ciliated ducts. Bronchiolar epithelial cells will be identified as ciliated, goblet, or Clara on the basis of specific antibody recognition. The expression and cellular location of the ion transport proteins CFTR and alpha, beta, and gamma subunits of the human epithelial Na+ channel will be determined by in situ hybridization and immunohistochemistry. Submucosal gland secretion volume, ion composition, and regulation will be measured using volume pipettes, ion-selective microelectrodes, and a human mucin-specific ELISA. Bronchiolar epithelial potential difference, airway surface liquid ion content, and ion transport regulation will be assessed with in vivo potential difference electrometers, ion-selective microelectrodes, and transport agonists and inhibitors. These morphometric, gene localization, and physiologic approaches will permit us to test the hypothesis that submucosal gland secretions are decreased in quantity in cystic fibrosis and to localize the bronchiolar region in which major salt and water absorption takes place. This improved understanding of human submucosal gland and bronchiolar physiology may elucidate mechanisms that are abnormal in cystic fibrosis and amenable to novel therapeutic approaches.